Riverside Capital has completed its latest capital raise this February. £4.5 million has been raised from private investors to facilitate the forward funding of the Cambridge Nutritional Sciences R&D property which has a target ERV of £9.7 million.

Construction of the property will now commence with a target completion date of early 2019.

Interested in Riverside Capital’s investment opportunities? Register as a client, or contact us to find out more.